Mechanisms underlying the inhibition of interferon signaling by viruses

Virulence

Volumn 5, Issue 2, 2014, Pages 270-277

  Devasthanam, Anand S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Antiviral drug target; Host virus interaction; Immune evasion; Interferon; Interferon signaling

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3; MDA5; RETINOIC ACID INDUCIBLE PROTEIN I; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VIRUS DNA;

BOVINE DIARRHEA VIRUS; CYTOKINE PRODUCTION; FLAVIVIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; INFLUENZA VIRUS A; INNATE IMMUNITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

ANTIVIRAL DRUG TARGET; HOST-VIRUS INTERACTION; IMMUNE EVASION; INTERFERON; INTERFERON SIGNALING;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERONS; SIGNAL TRANSDUCTION; VIRUSES;

EID: 84897836190     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27902     Document Type: Review

References (71)

1. Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks. Trends Immunol 2005; 26:396-401; PMID:15922665; http://dx.doi.org/10.1016/j. it.2005.05.004
2. Wilfert L, Jiggins FM. Host-parasite coevolution: genetic variation in a virus population and the interaction with a host gene. J Evol Biol 2010; 23:1447-55; PMID:20456575; http://dx.doi. org/10.1111/j.1420-9101.2010.02002.x
3. Lobo FP, Mota BE, Pena SD, Azevedo V, Macedo AM, Tauch A, Machado CR, Franco GR. Virushost coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hosts. PLoS One 2009; 4:e6282; PMID:19617912; http://dx.doi. org/10.1371/journal.pone.0006282
4. Vink C, Smit MJ, Leurs R, Bruggeman CA. The role of cytomegalovirus-encoded homologs of G proteincoupled receptors and chemokines in manipulation of and evasion from the immune system. J Clin Virol 2001; 23:43-55; PMID:11595583; http://dx.doi. org/10.1016/S1386-6532(01)00184-6
5. Taylor DJ, Ballinger MJ, Bowman SM, Bruenn JA. Virus-host co-evolution under a modified nuclear genetic code. PeerJ 2013; 1:e50; PMID:23638388; http://dx.doi.org/10.7717/peerj.50
6. Weber F, Kochs G, Haller O. Inverse interference: how viruses fight the interferon system. Viral Immunol 2004; 17:498-515; PMID:15671747; http://dx.doi.org/10.1089/vim.2004.17.498
7. McInerney GM, Karlsson Hedestam GB. Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses. J Innate Immun 2009; 1:599-606; PMID:20375615; http://dx.doi. org/10.1159/000235861
8. Schlender J, Hornung V, Finke S, Günthner-Biller M, Marozin S, Brzózka K, Moghim S, Endres S, Hartmann G, Conzelmann KK. Inhibition of tolllike receptor 7-and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 2005; 79:5507-15; PMID:15827165; http://dx.doi. org/10.1128/JVI.79.9.5507-5515.2005
9. Brzózka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005; 79:7673-81; PMID:15919920; http://dx.doi.org/10.1128/ JVI.79.12.7673-7681.2005
10. Nakatsu Y, Takeda M, Ohno S, Shirogane Y, Iwasaki M, Yanagi Y. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol 2008; 82:8296-306; PMID:18562542; http://dx.doi.org/10.1128/ JVI.00108-08
11. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009; 5:e1000287; PMID:19197350; http://dx.doi.org/10.1371/journal. ppat.1000287
12. Oshansky CM, Krunkosky TM, Barber J, Jones LP, Tripp RA. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol 2009; 22:147-61; PMID:19435411; http://dx.doi. org/10.1089/vim.2008.0098
13. Heise MT, Connick M, Virgin HW 4th. Murine cytomegalovirus inhibits interferon gammainduced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 1998; 187:1037-46; PMID:9529320; http://dx.doi.org/10.1084/jem.187.7.1037
14. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, García-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009; 5:439-49; PMID:19454348; http://dx.doi.org/10.1016/j. chom.2009.04.006
15. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 2010; 84:9452-62; PMID:20592086; http://dx.doi. org/10.1128/JVI.00155-10
16. Borrow P, Martínez-Sobrido L, de la Torre JC. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2010; 2:2443-80; PMID:21994626; http://dx.doi.org/10.3390/ v2112443
17. Gori-Savellini G, Valentini M, Cusi MG. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol 2013; 87:6660-7; PMID:23552410; http://dx.doi. org/10.1128/JVI.03129-12
18. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004; 101:17264-9; PMID:15563593; http://dx.doi. org/10.1073/pnas.0407639101
19. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80; PMID:11477402; http://dx.doi.org/10.1038/90609
20. Meylan E, Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 2006; 22:561-9; PMID:16762830; http://dx.doi.org/10.1016/j. molcel.2006.05.012
21. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998; 12:2061-72; PMID:9649509; http://dx.doi.org/10.1101/ gad.12.13.2061
22. Grimm S, Baeuerle PA. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J 1993; 290:297-308; PMID:8452515
23. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000; 74:7989-96; PMID:10933707; http://dx.doi.org/10.1128/ JVI.74.17.7989-7996.2000
24. Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, Gudkov AV. Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 2005; 280:24153-8; PMID:15845545; http://dx.doi. org/10.1074/jbc.M502303200
25. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, García-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 2000; 74:11566-73; PMID:11090154; http://dx.doi.org/10.1128/ JVI.74.24.11566-11573.2000
26. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, García-Sastre A, Heins G, Wolff T. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 2002; 76:11166-71; PMID:12368362; http://dx.doi.org/10.1128/ JVI.76.21.11166-11171.2002
27. Chen Z, Rijnbrand R, Jangra RK, Devaraj SG, Qu L, Ma Y, Lemon SM, Li K. Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus. Virology 2007; 366:277-92; PMID:17531282; http://dx.doi.org/10.1016/j. virol.2007.04.023
28. de Oliveira VL, Almeida SC, Soares HR, Crespo A, Marshall-Clarke S, Parkhouse RM. A novel TLR3 inhibitor encoded by African swine fever virus (ASFV). Arch Virol 2011; 156:597-609; PMID:21203785; http://dx.doi.org/10.1007/ s00705-010-0894-7
29. Vitour D, Doceul V, Ruscanu S, Chauveau E, Schwartz-Cornil I, Zientara S. Induction and control of the type I interferon pathway by Bluetongue virus. Virus Res 2013; (Forthcoming); PMID:24211608; http://dx.doi.org/10.1016/j.virusres.2013.10.027
30. Bao D, Wang R, Qiao S, Wan B, Wang Y, Liu M, Shi X, Guo J, Zhang G. Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages. Vet Immunol Immunopathol 2013; 156:128-34; PMID:24099951; http://dx.doi.org/10.1016/j. vetimm.2013.09.006
31. Peterhans E, Schweizer M. Pestiviruses: how to outmaneuver your hosts. Vet Microbiol 2010; 142:18-25; PMID:19846261; http://dx.doi.org/10.1016/j. vetmic.2009.09.038
32. Paulmann D, Magulski T, Schwarz R, Heitmann L, Flehmig B, Vallbracht A, Dotzauer A. Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J Gen Virol 2008; 89:1593-604; PMID:18559929; http://dx.doi.org/10.1099/ vir.0.83521-0
33. Lin L, Li Y, Pyo HM, Lu X, Raman SN, Liu Q, Brown EG, Zhou Y. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol 2012; 86:1942-54; PMID:22171255; http:// dx.doi.org/10.1128/JVI.06362-11
34. Horvath CM. The Jak-STAT pathway stimulated by interferon gamma. Sci STKE 2004; 2004:tr8; PMID:15561980
35. Stark GR, Kerr IM. Interferon-dependent signaling pathways: DNA elements, transcription factors, mutations, and effects of viral proteins. J Interferon Res 1992; 12:147-51; PMID:1379292; http://dx.doi. org/10.1089/jir.1992.12.147
36. Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, Gudkov AV. Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 2005; 280:24153-8; PMID:15845545; http://dx.doi. org/10.1074/jbc.M502303200
37. de Los Santos T, Diaz-San Segundo F, Grubman MJ. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 2007; 81:12803-15; PMID:17881445; http://dx.doi. org/10.1128/JVI.01467-07
38. Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M. The hepatitis C virus nonstructural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J Biol Chem 2003; 278:17775-84; PMID:12621033; http://dx.doi.org/10.1074/jbc.M210900200
39. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 2006; 80:5908-18; PMID:16731929; http://dx.doi. org/10.1128/JVI.02714-05
40. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 2009; 200:1261-70; PMID:19754307; http://dx.doi. org/10.1086/605847
41. Horvath CM. The Jak-STAT pathway stimulated by interferon alpha or interferon beta. Sci STKE 2004; 2004:tr10; PMID:15561979
42. Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 2001; 283:230-9; PMID:11336548; http://dx.doi. org/10.1006/viro.2001.0856
43. Ulane CM, Horvath CM. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002; 304:160-6; PMID:12504558; http://dx.doi. org/10.1006/viro.2002.1773
44. Rodriguez JJ, Wang LF, Horvath CM. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 2003; 77:11842-5; PMID:14557668; http://dx.doi. org/10.1128/JVI.77.21.11842-11845.2003
45. Rodriguez JJ, Cruz CD, Horvath CM. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 2004; 78:5358-67; PMID:15113915; http://dx.doi. org/10.1128/JVI.78.10.5358-5367.2004
46. Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex. Virology 2003; 306:135-46; PMID:12620806; http://dx.doi.org/10.1016/ S0042-6822(02)00026-0
47. Garcin D, Marq JB, Goodbourn S, Kolakofsky D. The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 2003; 77:2321-9; PMID:12551969; http:// dx.doi.org/10.1128/JVI.77.4.2321-2329.2003
48. Parisien JP, Lau JF, Rodriguez JJ, Ulane CM, Horvath CM. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 2002; 76:4190-8; PMID:11932384; http://dx.doi.org/10.1128/ JVI.76.9.4190-4198.2002
49. Gotoh B, Takeuchi K, Komatsu T, Yokoo J. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 2003; 77:3360-70; PMID:12610111; http://dx.doi.org/10.1128/ JVI.77.6.3360-3370.2003
50. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Häussinger D. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 2003; 17:488-90; PMID:12551851
51. Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 2004; 78:6282-6; PMID:15163721; http://dx.doi.org/10.1128/ JVI.78.12.6282-6286.2004
52. Fan L, Briese T, Lipkin WI. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 2010; 84:1785-91; PMID:20007272; http://dx.doi.org/10.1128/ JVI.01362-09
53. Pothlichet J, Chignard M, Si-Tahar M. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 2008; 180:2034-8; PMID:18250407
54. Pfaller CK, Li Z, George CX, Samuel CE. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr Opin Immunol 2011; 23:573-82; PMID:21924887; http://dx.doi. org/10.1016/j.coi.2011.08.009
55. Li Z, Okonski KM, Samuel CE. Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. J Virol 2012; 86:3787-94; PMID:22278222; http://dx.doi.org/10.1128/ JVI.06307-11
56. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007; 315:1137-40; PMID:17322061; http://dx.doi.org/10.1126/ science.1138050
57. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 2006; 13:13-21; PMID:16369484; http://dx.doi.org/10.1038/nsmb1041
58. Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 1992; 258:1369-72; PMID:1455233; http://dx.doi.org/10.1126/science.1455233
59. Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW, Ferguson BJ, Sumner RP. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013; 94:2367-92; PMID:23999164; http://dx.doi. org/10.1099/vir.0.055921-0
60. Amsler L, Verweij MC, DeFilippis VR. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol 2013; 425:4857-71; PMID:24013068; http://dx.doi. org/10.1016/j.jmb.2013.08.023
61. Zinzula L, Tramontano E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res 2013; 100:615-35; PMID:24129118; http://dx.doi. org/10.1016/j.antiviral.2013.10.002
62. Karim R, Tummers B, Meyers C, Biryukov JL, Alam S, Backendorf C, Jha V, Offringa R, van Ommen GJ, Melief CJ, et al. Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog 2013; 9:e1003384; PMID:23717208; http://dx.doi.org/10.1371/journal.ppat.1003384
63. Kolli D, Bao X, Casola A. Human metapneumovirus antagonism of innate immune responses. Viruses 2012; 4:3551-71; PMID:23223197; http://dx.doi. org/10.3390/v4123551
64. Ramanan P, Edwards MR, Shabman RS, Leung DW, Endlich-Frazier AC, Borek DM, Otwinowski Z, Liu G, Huh J, Basler CF, et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A 2012; 109:20661-6; PMID:23185024; http://dx.doi. org/10.1073/pnas.1213559109
65. Ye J, Zhu B, Fu ZF, Chen H, Cao S. Immune evasion strategies of flaviviruses. Vaccine 2013; 31:461-71; PMID:23153447; http://dx.doi.org/10.1016/j. vaccine.2012.11.015
66. Marsili G, Remoli AL, Sgarbanti M, Perrotti E, Fragale A, Battistini A. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion. Cytokine Growth Factor Rev 2012; 23:255-70; PMID:22748237; http://dx.doi.org/10.1016/j. cytogfr.2012.06.001
67. Paladino P, Mossman KL. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 2009; 29:599-607; PMID:19694546; http://dx.doi.org/10.1089/ jir.2009.0074
68. Österlund P, Strengell M, Sarin LP, Poranen MM, Fagerlund R, Melén K, Julkunen I. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 2012; 86:11183-93; PMID:22855501; http://dx.doi.org/10.1128/ JVI.01050-12
69. Kuehn BM. Silent epidemic of viral hepatitis may lead to boom in serious liver disease. J Am Med Assoc 1949-50; 2009:54
70. Manel N, Littman DR. Hiding in plain sight: how HIV evades innate immune responses. Cell 2011; 147:271-4; PMID:22000008; http://dx.doi. org/10.1016/j.cell.2011.09.010
71. Lee HR, Kim MH, Lee JS, Liang C, Jung JU. Viral interferon regulatory factors. J Interferon Cytokine Res 2009; 29:621-7; PMID:19715458; http://dx.doi. org/10.1089/jir.2009.0067